Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 29;9(1):82.
doi: 10.1038/s41541-024-00872-6.

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

Affiliations

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

Deborah F King et al. NPJ Vaccines. .

Abstract

On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including developers, manufacturers, regulators, public health officials and policy-makers from 17 countries, including 7 LMIC’s.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest other than Frederick Wittke and Stanley Plotkin. F.W. is an Employee of MSD, acting as TA Head European Clinical Development for Vaccines, and holds shares from MSD. S.P. consults for vaccine manufacturers including pharmaceutical and biotech companies, as well as non-profit organisations.

Figures

Fig. 1
Fig. 1
Simplified decision tree for consideration of correlates data in initial licensing of a vaccine.

References

    1. Immunization. https://www.who.int/news-room/facts-in-pictures/detail/immunization (2019).
    1. Vaccines and immunization. https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1 (2024).
    1. Lo AW, Siah KW, Wong CH. Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs. Harv. Data Sci. Rev. 2020 doi: 10.1162/99608f92.e0c150e8. - DOI
    1. MacPherson A, et al. Probability of success and timelines for the development of vaccines for emerging and reemerged viral infectious diseases. Ann. Intern. Med. 2021;174:326–334. doi: 10.7326/M20-5350. - DOI - PMC - PubMed
    1. How have Covid-19 vaccines been made quickly and safely? News, Wellcome. https://wellcome.org/news/quick-safe-covid-vaccine-development#the-usual... (2024).